Prophylactic use of the silver-acetate-coated graft in arterial occlusive disease: A retrospective, comparative study

Journal of Vascular Surgery

Volumn 50, Issue 4, 2009, Pages 790-798

  Larena Avellaneda, Axel ^a,b   Russmann, Sonja ^a   Fein, Martin ^a   Debus, Eike Sebastian ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; POLYESTER; SILVER;

AGED; ALLOGRAFT; ARTICLE; BLADDER INJURY; CLAUDICATION; CONTROLLED STUDY; FEMALE; FISTULA; GRAFT INFECTION; GRAFT PATENCY; HEART INJURY; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTESTINE INJURY; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE COMPLICATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; PROSTHESIS; SUBCUTANEOUS HEMORRHAGE; THROMBOSIS; URETER INJURY; WOUND HEALING IMPAIRMENT;

ACETATES; AGED; ANALYSIS OF VARIANCE; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CASE-CONTROL STUDIES; COATED MATERIALS, BIOCOMPATIBLE; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LEG; LIMB SALVAGE; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SILVER COMPOUNDS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 70349308230     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.05.003     Document Type: Article

References (35)

1. Ueberrueck T., Zippel R., Tautenhahn J., Gastinger I., Lippert H., and Wahlers T. Vascular graft infections: in vitro and in vivo investigations of a new vascular graft with long-term protection. J Biomed Mater Res B Appl Biomater 74 (2005) 601-607
2. Hernández-Richter T., Schardey H.M., Wittmann F., Mayr S., Schmitt-Sody M., Blasenbreu S., et al. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg 26 (2003) 550-557
3. Goëau-Brissonnière O.A., Fabre D., Leflon-Guibout V., Di Centa I., Nicolas-Chanoine M.H., and Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35 (2002) 1260-1263
4. O'Connor S.A. Efficacy of silver in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg 27 (2004) 565
5. Zegelmann M., and Günther G. Collagen-silver coated polyester grafts are the best "resistant to infection" synthetic grafts. Experience since 1999. In: Becquemin J.P., Loisance D., and Watelet J. (Eds). Controversies and update in vascular and cardiovascular surgery (2003), Minerva Medica, Turin 35-40
6. Batt M., Magne J.L., Alric P., Muzj A., Ruotolo C., Ljungstrom K.G., et al. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg 38 (2003) 983-989
7. Mirzaie M., Schmitto J.D., Tirilomis T., Fatehpur S., Liakopoulos O.J., Teucher N., et al. Surgical management of vascular graft infection in severely ill patients by partial resection of the infected prosthesis. Eur J Vasc Endovasc Surg 33 (2007) 610-613
8. Pounds L.L., Montes-Walters M., Mayhall C.G., Falk P.S., Sanderson E., Hunter G.C., and Killewich L.A. A changing pattern of infection after major vascular reconstructions. Vasc Endovascular Surg 39 (2005) 511-517
9. Ricco J.B., and InterGard Silver Study Group. InterGard silver bifurcated graft: features and results of a multicenter clinical study. J Vasc Surg 44 (2006) 339-346
10. Diehm C., Kareem S., and Lawall H. Epidemiology of peripheral arterial disease. Vasa 33 (2004) 183-189
11. Lansdown A.B. Silver in health care: antimicrobial effects and safety in use. Curr Probl Dermatol 33 (2006) 17-34
12. Tyndall S.H., Shepard A.D., Wilczewski J.M., Reddy D.J., Elliott Jr. J.P., and Ernst C.B. Groin lymphatic complications after arterial reconstruction. J Vasc Surg 19 (1994) 858-863 discussion 863-4
13. Giovannacci L., Eugster T., Stierli P., Hess P., and Gürke L. Does fibrin glue reduce complications after femoral artery surgery?. A randomised trial. Eur J Vasc Endovasc Surg 24 (2002) 196-201
14. Nevelsteen A., Suy R., Daenen W., Boel A., and Stalpaert G. Aortofemoral grafting: factors influencing late results. Surgery 88 (1980) 642-653
15. Nicoloff A.D., Taylor Jr. L.M., McLafferty R.B., Moneta G.L., and Porter J.M. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 27 (1998) 256-263 discussion 264-6
16. Panayiotopoulos Y.P., Tyrrell M.R., Owen S.E., Reidy J.F., and Taylor P.R. Outcome and cost analysis after femorocrural and femoropedal grafting for critical limb ischaemia. Br J Surg 84 (1997) 207-212
17. Sayers R.D., Thompson M.M., London N.J., Varty K., Naylor A.R., Budd J.S., et al. Selection of patients with critical limb ischaemia for femorodistal vein bypass. Eur J Vasc Surg 7 (1993) 291-297
18. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33 Suppl 1 (2007) S1-S75
19. Faries P.L., Logerfo F.W., Arora S., Hook S., Pulling M.C., Akbari C.M., et al. A comparative study of alternative conduits for lower extremity revascularization: all-autogenous conduit versus prosthetic grafts. J Vasc Surg 32 (2000) 1080-1090
20. Domenig C.M., Hamdan A.D., Holzenbein T.J., Kansal N., Aulivola B., Skillman J.J., et al. Timing of pedal bypass failure and its impact on the need for amputation. Ann Vasc Surg 19 (2005) 56-62
21. Zhang H., Zhang J.W., Shi Y.X., and Zhang B.G. Reoperations for occluded arterial bypasses in the lower limbs. Chin Med J (Engl) 119 (2006) 91-94
22. Raptis S., Faris I., Miller J., and Quigley F. The fate of the aortofemoral graft. Eur J Vasc Endovasc Surg 9 (1995) 97-102
23. Kram H.B., Gupta S.K., Veith F.J., and Wengerter K.R. Unilateral aortofemoral bypass: a safe and effective option for the treatment of unilateral limb-threatening ischemia. Am J Surg 162 (1991) 155-158
24. Aracil-Sanus E., Mendieta-Azcona C., Cuesta-Gimeno C., and Chinchilla-Molina A. Infragenicular bypass graft for limb salvage using polytetrafluoroethylene and distal vein cuff as the first alternative in patients without ipsilateral greater saphenous vein. Ann Vasc Surg 19 (2005) 379-385
25. Flis V., Pavlović M., and Miksic K. The value of adjunctive vein patches to improve the outcome of femorodistal polytetrafluoroethylene bypass grafts. Wien Klin Wochenschr 113 Suppl 3 (2001) 5-10
26. Kashyap V.S., Ahn S.S., Quinones-Baldrich W.J., Choi B.U., Dorey F., Reil T.D., et al. Infrapopliteal-lower extremity revascularization with prosthetic conduit: a 20-year experience. Vasc Endovascular Surg 36 (2002) 255-262
27. Chaw K.C., Manimaran M., and Tay F.E. Role of silver ions in destabilization of intermolecular adhesion forces measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 49 (2005) 4853-4859
28. Strathmann M., and Wingender J. Use of an oxonol dye in combination with confocal laser scanning microscopy to monitor damage to Staphylococcus aureus cells during colonisation of silver-coated vascular grafts. Int J Antimicrob Agents 24 (2004) 234-240
29. Lorentzen J.E., Nielsen O.M., Arendrup H., Kimose H.H., Bille S., Andersen J., et al. Vascular graft infection: an analysis of sixty-two graft infections in 2411 consecutively implanted synthetic vascular grafts. Surgery 98 (1985) 81-86
30. Hennes N., Sandmann W., Torsello G., Kniemeyer H.W., and Grabitz K. [Infection of a vascular prosthesis-a retrospective analysis of 99 cases.]. [Article in German]. Chirurg 67 (1996) 37-43
31. Szilagyi D.E., Smith R.F., Elliott J.P., and Vrandecic M.P. Infection in arterial reconstruction with synthetic grafts. Ann Surg 176 (1972) 321-333
32. Josephs L.G., Cordts P.R., DiEdwardo C.L., LaMorte W.W., and Menzoian J.O. Do infected inguinal lymph nodes increase the incidence of postoperative groin wound infection?. J Vasc Surg 17 (1993) 1077-1080 discussion 1080-2
33. Nguyen L.L., Lipsitz S.R., Bandyk D.F., Clowes A.W., Moneta G.L., Belkin M., and Conte M.S. Resource utilization in the treatment of critical limb ischemia: the effect of tissue loss, comorbidities, and graft-related events. J Vasc Surg 44 (2006) 971-975 discussion 975-6
34. Jamieson G.G., DeWeese J.A., and Rob C.G. Infected arterial grafts. Ann Surg 181 (1975) 850-852
35. Antonios V.S., Noel A.A., Steckelberg J.M., Wilson W.R., Mandrekar J.N., Harmsen W.S., and Baddour L.M. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect 53 (2006) 49-55